Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
TEVA is still selling plenty of Adderall XR
Who is this "We" you are referring to?
You've got to know when to let go.
https://www.chicagobusiness.com/health-care/akorn-files-bankruptcy-after-failed-takeover-fda-warnings
Who said this??
LOL. Spend your morning reading my old posts. It will do you some good. I'm going to wash my car.
You be you, I'll be me. Working out for me so far. I don't need to justify anything to you.
Great news.
I see we launched Adderall XR. I am very pleased and look forward to all the future revenue. I hope to see the next SunGen filing soon. I added 150K shares ELTP last week. I call this tranche the "Finish The Basement" tranche, which I hope to do in the next year. I don't want to seem impatient, but sharing the TV with my teenage children is becoming an issue, so let's get this show on the road to Dollarland.
Awesome job, Nasrat & Team.
Still no testing here.
Any test kit would fly
Who said that?
"Good news"
The oppressive boot of Big Government
I usually do not have the chance to listen to these calls, but I did today. I heard the CEO say in no uncertain terms that this company is being severely limited by over-regulation from the DEA of quota for methamphetamine API. I thought it was interesting that he specifically mentioned the current administration as the cause. In previous calls, he was confident that he could launch Adderall XR in just a few weeks because he knew he would have quota of API available from Adderall IR. But what he said today is that he could have sold even more IR by now if he had more quota. He cited the DEA's stinginess with API quota as the cause of any ongoing Adderall shortages.
In my opinion, Nasrat's refusal to provide any forward guidance has everything to do with his uncertainty about getting quota from the DEA. Whether by policy or lack of competent administration, the DEA has its regulatory boot on the neck of this company. Who is in charge of these Big Government thugs?
This is confusing.
Somebody better tell the lawyers.
I guess we can forget about the oxycodone patent suit with Purdue. I wonder if any of those attorneys know anything about class action shareholder cases. Maybe they could help out with that lawsuit instead, or whatever is coming down the pike.
First comes the volume...
...then comes the run.
Whoa there, Cowboy.
Welcome to the next phase...
Yesterday was the biggest day in the history of Elite Pharmaceuticals. We have never had any product with this much upside potential. It is particularly beneficial that the company has API quota in place and is ready to ship product within a few weeks to a distributor with the name and infrastructure to immediately start gaining market share. I say this is the "next phase" for two reasons: the IR and ER Adderall products will (1) make this company profitable (E is for earnings) and (2) allow further development without further dilution.
Congratulations to all long term investors. This is what we've been waiting for. Lots of investors have found this stock along the away, but I offer special praise to those investors with the insight and patience necessary to recognize the ongoing potential despite the recurrent setbacks. And while I am praising insight and patience, let's not forget Elite management. While the future of ADF opioids is in doubt, the future of Elite Pharmaceutical is very clear. For that fact alone, I give Nasrat Hakim great credit. I believe he showed true vision and was ahead of his peers in seeing problems in the ADF market and general decline in opioid prescriptions. The timely transition to ADHD drugs was a smart choice that aligns perfectly with Elite's model of niche drugs with high barriers to entry. The team has the facilities well-prepared, and the right products are starting to line up.
The next phase will require a second shift. It's time for our factory to get busy. We've literally got a license to cook crank, so let's really start slinging that speed!
Jenga!
That crazy tower was going to come tumbling down at some point- it always does. Can I keep my Antigen stock, or is that dividend also in divi-doubt?
If this MSO-pharmacy-wound care-surgery supply thing doesn't work out, maybe they should think about doing something with our totally unique, patented buccal insulin technology that has the potential to revolutionize diabetic management. Or just do the MSO. Whatever.
I would have lost that bet.
Purdue BK *before* IPCI.
¯\_( )_/¯
https://www.intellipharmaceutics.com/news-media/press-releases/detail/210/intellipharmaceutics-announces-an-update-in-the-purdue
Sounds like a sucker's bet.